U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07419035) titled 'Bipolar Radiofrequency for Genitourinary Syndrome of Menopause' on Feb. 11.
Brief Summary: This randomized, sham-controlled clinical trial aims to evaluate the efficacy and safety of bipolar radiofrequency in the treatment of genitourinary syndrome of menopause (GSM) in postmenopausal women. Participants will be randomly assigned to receive either active bipolar radiofrequency treatment or a sham procedure.
The primary objective is to determine whether bipolar radiofrequency improves vaginal and sexual function. Secondary objectives include assessment of pain with vaginal penetration, vaginal lubrication and tissue distensibility, ...